en
Scientific article
Open access
English

Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

Published inJournal of Antimicrobial Chemotherapy, vol. 70, no. 12, p. 3323-3331
Publication date2015
Abstract

The most recommended NRTI combinations as first-line antiretroviral treatment for HIV-1 infection in resource-rich settings are tenofovir/emtricitabine, abacavir/lamivudine, tenofovir/lamivudine and zidovudine/lamivudine. Efficacy studies of these combinations also considering pill numbers, dosing frequencies and ethnicities are rare.

Keywords
  • Adult
  • Antiretroviral Therapy
  • Highly Active/methods
  • Drug Resistance
  • Viral
  • Female
  • HIV Infections/drug therapy
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • Nucleosides/therapeutic use
  • Nucleotides/therapeutic use
  • Reverse Transcriptase Inhibitors/therapeutic use
  • Switzerland
  • Treatment Failure
Citation (ISO format)
YANG, Wan-Lin et al. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study. In: Journal of Antimicrobial Chemotherapy, 2015, vol. 70, n° 12, p. 3323–3331. doi: 10.1093/jac/dkv257
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0305-7453
368views
143downloads

Technical informations

Creation09/04/2018 2:34:00 PM
First validation09/04/2018 2:34:00 PM
Update time03/15/2023 1:08:43 PM
Status update03/15/2023 1:08:42 PM
Last indexation01/17/2024 3:58:12 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack